Latest News and Press Releases

ROCKVILLE, Md., Dec. 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Peter Greenleaf, Chief Executive...

Immediately Accretive to Revenue, Earnings and Operating Cash Flows Delivers Greater Manufacturing and Supply Chain Control Expands Sucampo's Product Pipeline ROCKVILLE, Md., Dec. 7, 2015...

ROCKVILLE, Md., Nov. 25, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at...

AMITIZA Revenue Performance Drives Income Growth R-Tech Ueno Tender Offer Achieved Threshold; Sucampo Closed on Debt Financing Company Reiterates 2015 Earnings Guidance Company to Host...

ROCKVILLE, Md., Oct. 22, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the closing of a $250.0 million credit...

ROCKVILLE, Md., Oct. 21, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its third quarter 2015...

Tender Achieves Threshold and Tender Offer Period Concludes Acquisition Expected to Close This Quarter BETHESDA, Md., Oct. 14, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo)...

BETHESDA, Md., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that Timothy P. Walbert has joined Sucampo's...

Acquisition Expected to be Immediately Accretive Advances Sucampo Strategy to Strengthen Financial Performance and Diversify Pipeline Acquisition Expected to Close in Q4 2015 Company to Host...

Year-over-Year Earnings Growth of 495% and EPS Growth of 425% Year-over-Year Revenue Growth of 45% Company Increases 2015 Earnings Guidance Company to Host Conference Call Today at 8:30 a.m....